Navigation Links
Gene therapy research from Penn Vet & Scheie Eye Inst. cures retinitis pigmentosa in dogs
Date:1/23/2012

PHILADELPHIA -- Members of a University of Pennsylvania research team have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retinitis Pigmentosa, or XLRP, in dogs.

The disease in humans and dogs is caused by defects in the RPGR gene and results in early, severe and progressive vision loss. It is one of the most common inherited forms of retinal degeneration in man.

"Every single abnormal feature that defines the disease in the dogs was corrected following treatment," said lead author William Beltran, assistant professor of ophthalmology at Penn's School of Veterinary Medicine.

"We were thrilled," said senior author Gustavo Aguirre, professor of medical genetics and ophthalmology at Penn Vet. "The treated cells were completely normal, and this effect resulted from introducing the normal version of the human gene into the diseased photoreceptor cells."

The similarities between humans and dogs, in terms of both eye anatomy, physiology, disease characteristics and positive response to this gene therapy, raise hope for a clear path to human therapies.

Beltran and Aguirre collaborated with Artur Cideciyan and Samuel Jacobson at the Scheie Eye Institute, part of the University of Pennsylvania's Perelman School of Medicine. This achievement results from more than 10 years of close collaboration between the scientists at Penn's veterinary and medical Schools and the University of Florida.

In addition to others at Penn Vet, Scheie and Florida, researchers at the universities of Michigan and Massachusetts and the National Eye Institute at the National Institutes of Health contributed to the research.

The study will be published in the journal Proceedings of the National Academy of Sciences.

The gene therapy approach used takes advantage of a viral vector a genetically modified virus that doesn't cause disease and is unable to divide -- to deliver the
'/>"/>

Contact: Evan Lerner
elerner@upenn.edu
215-573-6604
University of Pennsylvania
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
2. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
3. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
4. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
5. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
6. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
7. Progenitor Cell Therapy Secures Industry Accreditation
8. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
9. Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
10. First Coast Oncology to Offer Next Generation Proton Therapy
11. Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... The "Operating Room Management Market ... Application (Perioperative, Preoperative, operating room Scheduling), by Component ... Global Forecast to 2019.” defines and segments the ... forecast of value by product, such as data ... the value and volumes of operating room management ...
(Date:11/15/2014)... 2014 The report “Laboratory ... End-User - Global Forecasts to 2019”, defines ... an analysis and forecast of value by ... Osmosis. Along with this, the value of ... regions are also discussed in the report. ...
(Date:11/15/2014)... 2014 Anthera Pharmaceuticals, Inc. (NASDAQ: ... for the third quarter ended September 30, 2014. ... September 30, 2014 was $7.0 million, compared to $5.8 ... in net loss is mainly driven by higher research ... progress in both our Phase 3 systemic lupus erythematosus ...
(Date:11/12/2014)... , 12. November 2014 /PRNewswire/ ... RaySafe, ist weltweit führend in der ... biomedizinische Tests und Simulationen und diagnostische ... Nach dem erfolgreichen ... nun branchenweit in Hinsicht auf Produktqualität, ...
Breaking Biology Technology:Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 2Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 3Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 4Laboratory Filtration Market worth $2,532.6 Million by 2019 - New Report by MarketsandMarkets 2Laboratory Filtration Market worth $2,532.6 Million by 2019 - New Report by MarketsandMarkets 3Laboratory Filtration Market worth $2,532.6 Million by 2019 - New Report by MarketsandMarkets 4Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 2Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 3Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 4Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 5Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 6Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 2Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 3Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 4Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 5
... Sept. 9 Energy crop company,Ceres, Inc. announced ... high-biomass sorghum hybrids with Range Fuels, Inc. as ... site of Range Fuels,commercial-scale cellulosic ethanol plant, now ... of Atlanta., While wood residues will be ...
... to ... economy, ... business development projects is being recognized by,Area Development magazine, which awarded ... awarded to states that have generated,top job-creation and capital investment projects ...
... chemistry Professor Harry Dorn has developed a new area of ... molecular semiconductors and quantum computing applications. , Dorn plays ... they are tinker toys. First, in 1999, he figured out ... to do it reliably, how to change the number of ...
Cached Biology Technology:Ceres Trials Energy Crops at Georgia Biofuel Facility 2Ceres Trials Energy Crops at Georgia Biofuel Facility 3Ohio Recognized as National Leader for Business Development and Job Creation 2Ohio Recognized as National Leader for Business Development and Job Creation 3Carbon molecule with a charge could be tomorrow's semiconductor 2
(Date:11/3/2014)... A University of Colorado Cancer Center study ... Academy of Sciences describes the activity of a ... Interleukin 37 or IL-37. It has been known to ... in the adaptive immune system: IL-37 inhibits the ability ... antigens. , "Knowing this mechanism that underlies IL-37,s effect ...
(Date:11/2/2014)... (2 November 2014)—In support of a bold quest to ... Melinda Gates Foundation today announced an award of US$156 ... Initiative (MVI) in building new vaccines that will interrupt ... the "accelerating to zero" agenda. Such vaccines would ensure ... be called an "immunological bed net." , This ...
(Date:10/31/2014)... largest producer of cocoa. Chocolate trees ( Theobroma cacao ... of rainforest in the state of Bahia, beneath a ... rainforest was a biodiversity hotspot, the chocolate trees, which ... in the mid 1700s, had very low levels of ... scenario created a very romantic, but extremely fragile situation". ...
Breaking Biology News(10 mins):PNAS: From HIV to cancer, IL-37 regulates immune system 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4Scientists seek cure for devastating witches' broom disease of the chocolate tree 2Scientists seek cure for devastating witches' broom disease of the chocolate tree 3
... progression of a lethal type of brain tumor with reduced ... complex the immune response is to the cancer and the ... Previous research found that people with allergies were ... cancer, called glioblastoma multiforme. However, it was not clear whether ...
... improved snacks and a la carte offerings to meet ... physical activity did not improve in most schools, according ... the few states to collect and analyze plans to ... projects coordinator, Project PA. Project PA, a collaboration between ...
... EAST LANSING, Mich. States aiming to lead the ... subsidies and tax incentives to ethanol producers just to ... "State subsidies have played an important role in ... of agricultural, food and resource economics. "The size of ...
Cached Biology News:Brain tumor growth linked to lowered expression of hundreds of immune function genes 2Brain tumor growth linked to lowered expression of hundreds of immune function genes 3Pennsylvania makes inroads into reducing child obesity 2State biofuel subsidies costly but effective, MSU research shows 2
... The Aquarius 384 is a ... Aquarius 384-well head is a unique ... washing using the included wash system. ... 250 microplate stacker system. Will ...
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... it easy to supply microplates, deepwells, and ... operator convenience in mind, iLink incorporates multiple ... use. The iLink software is the key ... sub-assays, that can be copied and installed ...
... products bring you ease of use and rapid solutions to meet your laboratory's requirements for data ... ... ... CLARA® is the standard software for Staccato Systems ...
Biology Products: